Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
04.11.24
/
50%
€80.00
Target price
04.11.25
€81.61
Performance (%)
53.75%
End price
05.11.25
-
Summary
This prediction is currently being closed. With a performance of 53.75% the BUY prediction by JPMorgan_Chase___Co_ is a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at JPMorgan Chase & Co. from $81.00 to $89.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.00
21.08.24
21.08.24
€72.78
21.08.25
21.08.25
80.88%
22.08.25
22.08.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
12.06.24
12.06.24
€72.03
12.06.25
12.06.25
92.19%
13.06.25
13.06.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€41.80
09.03.23
09.03.23
€54.81
09.03.24
09.03.24
45.22%
10.03.24
10.03.24